BPC
AZN icon

Bearing Point Capital’s AstraZeneca AZN Stock Holding History

Bearing Point Capital’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
5,862
+29
+0.5% +$5.59K 0.18% 90
2025
Q4 		$1.07M Buy
5,833
+297
+5% +$52.1K 0.17% 99
2025
Q3 		$849K Sell
5,536
-463
-8% -$70.1K 0.15% 97
2025
Q2 		$838K Sell
5,999
-512
-8% -$71.8K 0.15% 95
2025
Q1 		$957K Buy
6,511
+807
+14% +$117K 0.2% 91
2024
Q4 		$747K Buy
+5,704
New +$799K 0.16% 100

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Bearing Point Capital's AZN Position: Q1 2026 in Review

Bearing Point Capital increased its AstraZeneca (AZN) stake by 0.5% in Q1 2026, buying an estimated $5.59K and bringing the position to 5,862 shares worth $1.16M. The position accounts for 0.18% of the portfolio, ranked #90.

Bearing Point Capital first reported a position in AZN in Q4 2024 and has held it in 6 quarters since. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Bearing Point Capital held 5,862 shares of AstraZeneca worth $1.16M as of Q1 2026.
  • Bearing Point Capital bought 29 AstraZeneca shares in Q1 2026, an estimated $5.59K.
  • AstraZeneca made up 0.18% of Bearing Point Capital's portfolio in Q1 2026, its #90 holding.
  • Bearing Point Capital first reported a position in AstraZeneca in Q4 2024 and has held it in 6 quarters since.
  • 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Bearing Point Capital's 13F filing for Q1 2026, filed 7 May 2026.